PLSE Q4 2021 Earnings — Pulse Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

PLSEPulse Biosciences, Inc.

$1B

Q4 2021 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$844,000

Gross Profit

-$397,000-47.0% margin

Operating Income

-$15M-1825.8% margin

Net Income

-$15M-1826.5% margin

EPS (Diluted)

$-0.52

QoQ Revenue Growth

+47.0%

Cash Flow

Operating Cash Flow

-$13M

Free Cash Flow

-$13M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$54M

Total Liabilities

$19M

Stockholders' Equity

$36M

Cash & Equivalents

$29M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$844,000	$0	—
Gross Profit	-$397,000	$0	—
Operating Income	-$15M	-$14M	-12.0%
Net Income	-$15M	-$14M	-12.1%